We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





New Coronavirus Test Works 10 Times Faster

By LabMedica International staff writers
Posted on 14 Apr 2020
Print article
Illustration
Illustration
A new testing method for COVID-19 can confirm the presence of the virus 4-10 times faster than the current method of extracting ribonucleic acid (RNA) molecules from a patient’s swab sample to see whether they contain viral RNA. In addition to being equally accurate, the new test does not use specially produced test kits or reagents needed for extracting RNA and instead uses materials commonly found in diagnostic labs, thus making it significantly cheaper and reducing dependence on imported testing materials.

The new testing method for COVID-19 has been developed by researchers from the Hebrew University of Jerusalem (Jerusalem, Israel). The COVID-19 testing kits currently in use extract RNA molecules from a patient's sample to determine if they have viral RNA within them to confirm the presence of the coronavirus. However, these test kits require testing materials, such as complex reagents to extract the RNA for analysis, which are in short supply globally, thus slowing down the rate of testing and increasing the rate of infection.

The Hebrew University researchers have devised a new COVID-19 testing method using a homemade solution that is more easily available and cheaper than the kits. Instead of complex reagents, their test uses tiny magnetic beads to extract RNA for analysis and can be performed both robotically as well as manually. The beads are also recyclable and can be reused to perform future tests. The method was tested on hundreds of samples and all the tests came out identical to the results obtained using the current test kits. The bead method extracted RNA is also ready for analysis four to 10 times more quickly than most other methods.

The researchers believe if their COVID-19 testing method can help labs significantly eliminate the testing bottleneck by reducing their dependence on external factors. The researchers are now developing a method based on genomic sequencing tools that will allow tens of thousands of samples to be tested simultaneously instead of the current rate of thousands of tests.

Related Links:
The Hebrew University of Jerusalem
Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Malaria Rapid Test
OnSite Malaria Pf/Pan Ag Rapid Test
New
Liquid Based Cytology Production Machine
LBP-4032

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.